InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Leftwich Scott. Director active across 1 company, notably Calidi Biotherapeutics, Inc.. In total, 5 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €215k. History available since 21 December 2023. The latest transaction was disclosed on 21 August 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Leftwich Scott is an insider, with 5 filings in total, all linked to Calidi Biotherapeutics, Inc. on XNAS, where he is a Director. In the 5 most recent sampled filings, buys total EUR 215275, sells total EUR 0, and the period runs from 2024-01-04 to 2025-08-25. The modal transaction nature is Attribution.